World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Bristol in Development Deal for Hepatitis C Treatment
Keywords:
Tags: Pharmaceutical,
Bristol Myers deal with ZymoGenetics for development of Hepatitis C drug
01/12/2009
Grouped Articles
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
AbbVie Pins Hopes on Hepatitis C Treatment
Wall Street Journal 12/18/2014
Bristol-Myers’ Pricey Pipeline
Wall Street Journal 07/24/2015
Bristol-Myers acqusitions
01/12/2009
Grouped Articles
Bristol Will Buy Diabetes Drug Maker
Wall Street Journal 06/30/2012
Bristol-Myers to Buy ZymoGenetics for $885 Million
New York Times 09/07/2010
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
Bristol-Myers’ Pricey Pipeline
Wall Street Journal 07/24/2015
Bristol Tie-Up Targets Hepatitis C
Wall Street Journal 01/09/2012
Bristol-Myers to Acquire Inhibitex
New York Times 01/09/2012
Bristol-Myers R&D
01/12/2009
Grouped Articles
Bristol-Myers to End Some Drug Discovery
Wall Street Journal 11/09/2013
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
Bristol-Myers: Big Spending Has Big Rewards
Wall Street Journal 11/30/2015
Bristol Myers ZymoGenetics acquisition
01/12/2009
Grouped Articles
Bristol-Myers to Buy ZymoGenetics for $885 Million
New York Times 09/07/2010
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
Bristol-Myers performance
01/12/2009
Grouped Articles
Bristol Will Buy Diabetes Drug Maker
Wall Street Journal 06/30/2012
Bristol-Myers to Buy ZymoGenetics for $885 Million
New York Times 09/07/2010
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
Bristol-Myers’ Pricey Pipeline
Wall Street Journal 07/24/2015
Bristol-Myers: Big Spending Has Big Rewards
Wall Street Journal 11/30/2015
Bristol Tie-Up Targets Hepatitis C
Wall Street Journal 01/09/2012
Bristol-Myers strategies
08/01/2008
Grouped Articles
Bristol Will Buy Diabetes Drug Maker
Wall Street Journal 06/30/2012
Bristol-Myers to End Some Drug Discovery
Wall Street Journal 11/09/2013
Bristol-Myers to Buy ZymoGenetics for $885 Million
New York Times 09/07/2010
Bristol in Development Deal for Hepatitis C Treatment
Wall Street Journal 01/12/2009
Bristol-Myers’ Pricey Pipeline
Wall Street Journal 07/24/2015
Bristol-Myers: Big Spending Has Big Rewards
Wall Street Journal 11/30/2015
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us